EP1381644A2 - Antimikrobielle kautschukzusammensetzung - Google Patents

Antimikrobielle kautschukzusammensetzung

Info

Publication number
EP1381644A2
EP1381644A2 EP02753761A EP02753761A EP1381644A2 EP 1381644 A2 EP1381644 A2 EP 1381644A2 EP 02753761 A EP02753761 A EP 02753761A EP 02753761 A EP02753761 A EP 02753761A EP 1381644 A2 EP1381644 A2 EP 1381644A2
Authority
EP
European Patent Office
Prior art keywords
rubber
silver
article
formulation
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02753761A
Other languages
English (en)
French (fr)
Other versions
EP1381644A4 (de
Inventor
John G. Lever
Geoffrey R. Haas
Bhawan Patel
William O. Burke Iii
Robert C. Kerr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Milliken and Co
Original Assignee
Milliken and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/815,730 external-priority patent/US6455610B1/en
Priority claimed from US09/815,637 external-priority patent/US6448306B1/en
Priority claimed from US09/815,483 external-priority patent/US6555599B2/en
Application filed by Milliken and Co filed Critical Milliken and Co
Publication of EP1381644A2 publication Critical patent/EP1381644A2/de
Publication of EP1381644A4 publication Critical patent/EP1381644A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/06Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/01Use of inorganic substances as compounding ingredients characterized by their specific function
    • C08K3/015Biocides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0008Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C08K5/0058Biocides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/14Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602Type of release, e.g. controlled, sustained, slow

Definitions

  • This invention relates to certain non-silicone pre-vulcanized and/or vulcanized raw rubber formulations that include silver-based compounds to provide highly desirable long- term antimicrobial characteristics (or within the ultimate cured rubber articles made therefrom such pre-vulcanized formulations).
  • Such formulations are intended to be vulcanized to provide solid or blown (foam or sponge) rubber articles which can be utilized in a variety of different applications (as well as multi-layered composites) including such antimicrobial rubber.
  • silver-based compounds are deleteriously affected by utilization of standard curing agents and curing accelerators, such as sulfur-based compounds and/or systems, the ability to provide such an effective antimicrobial vulcanized rubber article is rather difficult.
  • this invention encompasses the presence of different non-sulfur-based curing systems and curing agents, such as inorganic and organic peroxides and oxides, as some examples, that permit vulcanization and do not irreversibly bind silver ions thereto, thereby resulting in long-term antimicrobial performance of the ultimate rubber article itself.
  • the raw or cured rubber formulations may also comprise fillers and may also include plasticizers to provide desired characteristics of dimensional stability, stiffness, flexural modulus, tensile strength, abrasion resistance, elongation, and the like, for the ultimate rubber article, while simultaneously and surprisingly enlmncing the control of antimicrobial efficacy in the rubber article as well.
  • triclosan The most popular antimicrobial agent for such articles is triclosan. Although the incorporation of such a compound within a liquid or certain polymeric media has been achieved, other substrates, specifically vulcanized rubber and surfaces thereof, have proven less accessible. For instance, triclosan itself diffuses easily within and out of polymeric substrates and/or matrices,and thus is not very durable. Furthermore, triclosan lacks the desired thermal stability for plastic processing at high temperatures, and does not provide a wide range of bacterial kill. For instance, triclosan does not exhibit any kill for Pseudomonas , aeruginosa.
  • Antimicrobial raw rubber formulations are certainly highly desired for the production of vulcanized rubber articles to provide not only antibacterial benefits, but also antifungal, antimildew, antistaining, and odor control properties.
  • Rubber articles are utilized in many different applications, including automobiles (hoses, tires, bumpers, etc.), food processing equipment (conveyor belts, wheels, tubing, gaskets), household items (toys, sink washers, gaskets, appliances, rubber door mats, rubber floor mats, carpeted floor or door mats, gloves, and the like), basically any rubber applications in which bacterial and fungal growth is a potential problem.
  • Japanese Patent Application 1997-342076 discloses the production of unvulcanized rubber formulations and articles exhibiting antibacterial properties due to the presence of silver complexes. Such formulations are formed through high temperature kneading in an oxygen-free atmosphere and are used as parts in a water disinfection system. Again, no vulcanized rubber is taught or obtained within or through this disclosure. Antimicrobial rubber bands have been taught in Japanese Patent Application 1997-140034 in vulcanized form with silver antimicrobials therein. However, such compounds are rather limited in use and the vulcanization step must include a sulfur curing agent to effectuate the final vulcanized arrangement of the subject rubber.
  • Such sulfur curing agents have a remarkably deleterious effect on certain silver-based antimicrobials such that the sulfur reacts with the silver ion, to form silver sulfide, thus rendering it ineffective as a bactericide.
  • the utilization of such specific rubber band formulations for and within large-scale antimicrobial articles is basically unworkable.
  • Certain types of antimicrobial peroxide-catalyst vulcanized rubber formulations have been produced in the past; however, such peroxide-cured rubbers are all silicone-based. It is well understood and accepted that silicone rubbers cannot be vulcanized by typical sulfur- based catalysts.
  • the antimicrobial rubber formulations of Japanese Patent Applications 1997-026273 and 1995-065149 as well as U.S. Pat. No.
  • 5,466,726 are standard vulcanized silicone rubber formulations and articles which also include certain antimicrobial compounds. Furthermore, rubber latexes (non-vulcanized) comprising antimicrobials have been disclosed (U.S. Pat. No. 5,736,591, for example), as have floor mats having silver-based antimicrobials incoiporated within pile fiber components and which have non-antimicrobial rubber backings cured through peroxide-catalyzed vulcanization to protect the pile fiber antimicrobial compounds from attack by any sulfur compounds (as in Japanese Patent
  • Another object of the invention is to ultimately provide an antimicrobial non-silicone pre-vulcanized rubber formulation comprising silver-based antimicrobial compounds which include curing agents and curing accelerators which do not deleteriously effect the antimicrobial activity of the ultimate vulcanized rubber article (and thus is essentially free from sulfur-based curing agents and accelerators).
  • Yet another object of this invention is to provide an unvulcanized non-silicone raw rubber formulation that, upon vulcanization, cures to form such an inventive antimicrobial non-silicone vulcanized rubber article exhibiting log kill rates for Staphylococcus aureus and Klebsiella pneumoniae (and/or other types of bacteria as well) of at least 1.0 after 24 hours exposure at room temperature.
  • Still another object of the invention is to provide an unvulcanized rubber formulation that, upon vulcanization, cures to form an antifungal article exhibiting at least 70% inhibition in accordance with Test Method ISO 486, of Aspergillus niger, Paecilomyces variotii, and Trichoderma virens (and/or other types of fungi as well) for at least 15 days at 30°C and at greater than 90% humidity.
  • Still another object of this invention is to provide an unvulcanized non-silicone raw rubber formulation comprising structural integrity filler components (e.g., carbon black, silica, metal salts, organic salts, metal oxides, and the like) and plasticizers (e.g., phthalate oil, paraffinic oil, and the like) that provide enhancements in the control of antimicrobial efficacy of such a rubber article through controlled silver ion release to the article surface.
  • structural integrity filler components e.g., carbon black, silica, metal salts, organic salts, metal oxides, and the like
  • plasticizers e.g., phthalate oil, paraffinic oil, and the like
  • Still another object of the invention is to provide a finished article that exhibits increases in antimicrobial activity after industrial washing and/or abrasion.
  • Still another object of this invention to provide an antimicrobial dimensionally stable vulcanized rubber article (comprising, for example, EPDM, NBR, or natural rubber) exhibiting sufficient antimicrobial activity and structural integrity to withstand repeated use without losing an appreciable level of either antimicrobial power or modulus strength.
  • Another object of the invention is to provide an antimicrobial vulcanized EPDM, NBR, or natural rubber article comprising silver-based antimicrobial compounds which include curing agents which do not deleteriously effect the antimicrobial activity of the finished vulcanized EPDM, NBR, or natural article (and thus is essentially free from sulfur-based curing agents and accelerators).
  • Yet another object of this invention is to provide a vulcanized EPDM rubber-containing article that exhibits log kill rates for Staphylococcus aureus and Klebsiella pneumoniae (and/or other types of bacteria as well) of at least 1.0 after 24 hours exposure at room temperature as well as prevention of growth of certain fungi after at least 15 days of exposure.
  • Still another object of this invention is to provide a vulcanized EPDM, NBR, or natural rubber-containing article comprising structural integrity filler components and plasticizers (such as silica, metal salts, organic salts, pigments, such as carbon black, calcium carbonate, paraffinic oils, phthalate oils, metal oxides, and the like) that also provide enhancements in the control of antimicrobial efficacy of the article itself through regulated silver ion release to the article surface (e.g., exhibits higher log kill rates for Staphylococcus aureus and Klebsiella pneumoniae and prevention of growth of fungi such as Aspergillus niger).
  • plasticizers such as silica, metal salts, organic salts, pigments, such as carbon black, calcium carbonate, paraffinic oils, phthalate oils, metal oxides, and the like
  • Still another object of the invention is to provide a finished article that exhibits increases in antimicrobial activity after industrial washing and/or abrasion. Yet another object is to provide a simple method of producing such an atimicrobial vulcanized EPDM, NBR, or natural rubber-containing article.
  • this invention encompasses a non-silicone unvulcanized raw rubber formulation comprising at least one rubber constituent, at least one silver-based antimicrobial compound, and at least one curing catalyst compound, wherein said catalyst does not include an appreciable amount of sulfur-based curing agent and/or accelerator compound or compounds, and wherein said rubber formulation optionally comprises a blowing agent, and at least one filler component.
  • a raw rubber formulation can be subsequently cured (vulcanized) in the presence of the substantially non-sulfur based curing agents to produce a resilient antimicrobially effective rubber article that exhibits dimensional stability.
  • This invention further encompasses a dimensionally stable vulcanized rubber-containing article exhibiting log kill rates for Staphylococcus aureus and Klebsiella pneumoniae of at least 1.0 each after 24 hours exposure at room temperature (such as EPDM, NBR, and/or natural rubber-based). Also, this invention encompasses a dimensionally stable vulcanized rubber- containing article exhibiting antifungal properties such that said article exhibits at least 70% inhibition in accordance with Test Method ISO 486, of Aspergillus niger ATCC 6275 for at least 15 days at 30°C and at greater than 90% humidity.
  • this invention encompasses such a vulcanized rubber-containing article comprising at least one silver ion control release additive, such as those selected selected from the group consisting of fillers (such as carbon black, calcium carbonate, inorganic salts, organic salts, silica, and mixtures thereof) and plasticizers (oils such as phthalate oils and paraffinic oils).
  • fillers such as carbon black, calcium carbonate, inorganic salts, organic salts, silica, and mixtures thereof
  • plasticizers oils such as phthalate oils and paraffinic oils
  • this invention encompasses a method of producing a vulcanized rubber-containing article comprising the steps of providing a rubber formulation comprising uncured rubber, at least one non-sulfur based curing agent, and at least one silver-based antimicrobial compound, and vulcanizing said rubber formulation at a temperature of at least 150°C and at least at a pressure of 3 bars, wherein said rubber formulation is substantially free from sulfur curing agent and accelerator.
  • dimensionally stable is intended to encompass a vulcanized rubber article that is structurally able to be handled without disintegrating into smaller portions.
  • the article must exhibit some degree of structural integrity and, being a rubber, a certain degree of flexural modulus.
  • certain fillers and oils are required to provide both flexural modulus and structural integrity to vulcanized rubber articles.
  • the rubber component alone generally does not exhibit proper dimensional stability without such additives.
  • the presence of such additives also provides the ability to control silver-ion release at the target article surface. Without intending to be bound to any specific scientific theory, it appears that such fillers as silica and such oils as paraffinic oil (as some examples), act in such a way as to draw moisture into the article which then transports silver ions from within the article to the surface.
  • the rubber article may exhibit enhanced silver release resulting in higher log kill rates for certain bacteria due to the presence of larger amounts of available surface silver ions.
  • Other fillers such as pigments (for example, carbon black) and calcium carbonate (as some examples) appear to work in the opposite manner by keeping water out of the target article and thus prevent silver-ion migration to the article surface.
  • the reduction of such silver-ion availability increases the long term durability of the antimicrobial article.
  • the actual antibacterial efficacy of the entire rubber article can be controlled through the presence of certain amounts of such generally required fillers and oils (some hydrophilic antistatic agents also appear to act in the same manner as silica as well).
  • rubber as noted above, is intended to cover any standard rubber which must be vulcanized to provide a dimensionally stable rubber article.
  • inventive rubber formulations should also possess a chemical plasticizer which aids in the breakdown period of the elastomer during compounding and processing (and provides flexural modulus properties to the finished article) as well as fillers required for reinforcement (e.g. calcium carbonate, carbon black, silica, and clays).
  • a blowing agent may be added to the inventive formulation.
  • the rubber component or components of the inventive raw or cured rubber formulation is therefore selected from the group consisting of nitrile rubber [such as acrylonitrile-butadiene (NBR)], styrene-butadiene rubber (SBR), chloroprene, ethylene propylene diene comonomer (EPDM), natural rubber, polyurethane rubber, butyl rubbers, neoprene, isoprene, halobutyl rubbers, fluoroelastomers, epichlorohydrin rubber, polyacrylate rubber, and chlorinated polyethylene rubber.
  • Modified rubbers which are potentially useful, though more expensive, include hydrogenated SBR, hydrogenated NBR, and carboxylated NBR and the like.
  • silicone-rubber Although the presence of silicone-rubber is discouraged within the inventive formulation, there remains the possibility of adding certain low amounts of such specific unvulcanized rubber components without adversely affecting the overall antimicrobial rubber formulation itself. Thus, up to 25% by total weight of the formulation may be silicone-rubber; however, the vast majority of the rubber formulation must be non- silicone rubber. Furthermore, the non-silicone rubber portion must not possess an appreciable amount of sulfur-based curing agent or residue (in the finished article) and thus must be vulcanized through curing with primarily non-sulfur-based compounds (such as peroxides and metal oxides, for example).
  • the rubber component is present in amount of from about 10 to about 1,000 parts of the entire composition, more preferably from about 50 to about 500 parts, and most preferably from about 100 to about 200 parts.
  • the rubber constitutes from about 25 to about 70% of the percentage by parts of the entire formulation (and article).
  • the remainder comprises additives such as fillers, oils, curing agents, the desired antimicrobial agents, optional blowing agents, and the like (as discussed more thoroughly below).
  • non-silicone rubber portion must not possess an appreciable amount of sulfur-based curing agent or residue (in the finished article) and thus must be vulcanized through curing with primarily non-sulfur-based compounds (such as peroxides and metal oxides, for example).
  • the rubber component is present in amount of from about 10 to about 1,000 parts of the entire composition, more preferably from about 50 to about 500 parts, and most preferably from about 100 to about 200 parts.
  • the antimicrobial agent of the inventive raw or cured rubber formulation may be of any standard silver-based compounds.
  • Such compounds in contrast with organic types, such as triclosan, for example, do not exhibit low thermal stability and thus remain within the target matrix or substrate at different temperatures. Thus, such an antimicrobial is more easily controlled, as discussed above, for surface release as desired.
  • Such agents include, without limitation, silver salts, silver oxides, elemental silver, and, most preferably ion exchange, glass, and/or zeolite compounds. Of even greater preference are silver-based ion exchange compounds for this purpose due to the low levels of discoloration and enhanced durability in the final product provided by such compounds, the efficacy provided to the final formulation with such a compound, and the ease of manufacture permitted with such specific compounds.
  • the antimicrobial agent of this invention may be any type which imparts the desired log kill rates as previously discussed to Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa, as merely representative organisms.
  • antimicrobial compounds must be able to withstand elevated processing temperatures for successful incorporation within the target non-sulfur (peroxide, for example) inventive cured rubber formulations.
  • antimicrobial agents comprise, preferably, silver-containing ion exchange, glass, and/or zeolite compounds.
  • such a compound is a silver-based ion-exchange compound and particularly does not include any added organic bactericide compounds (thereby not permitting a release of volatile organic compounds into the atmosphere during processing at high temperatures, etc.).
  • the preferred silver-based ion exchange material is an antimicrobial silver zirconium phosphate available from Milliken & Company, under the trade name ALPHAS AN®.
  • Such compounds are available in different silver ion concentrations as well as mixtures with zinc oxide.
  • different compounds of from about 0.01 to 10% of silver ion concentration preferably from about 3 to about 8% redirect and most preferably amounts of about 3, 3.8, and 10% by total amount of components (e.g. of the total amount of silver ions and zirconium phosphate) are possible.
  • silver-containing solid inorganic antimicrobials in this invention are silver-substituted zeolite available from Sinanen under the tradename ZEOMIC®, or a silver-substituted glass available from Ishizuka Glass under the tradename IONPURE®, which may be utilized either in addition to or as a substitute for the preferred species.
  • Other possible compounds again without limitation, are silver-based materials such as MICROFREE®, available from DuPont, as well as JMAC®, available from Johnson Mathey.
  • such an antimicrobial compound is added to a rubber formulation in an amount of from about 0.1 to 10% by total weight of the particular total rubber formulation; preferably from about 0.1 to about 5%; more preferably from about 0.1 to about 2%; and most preferably from about 0.2 to about 2%.
  • silver-based inorganic antimicrobial materials these particular antimicrobial rubber articles are shown to be particularly suitable for the desired r high levels of efficacy and durability required of such articles. It has been found that certain silver-based ion exchange compounds, such as ALPHASAN® brand antimicrobials available from Milliken & Company, (U.S. Patent 5926238, U.S. Patent 5441717, U.S. Patent 5698229 to Toagosei Chemical Industry Inc.), exhibit spectacular bio-efficacy. After a period of time, alternative antimicrobial compounds (e.g.
  • triclosan, Microchek, OBPA, Zn-omadine initially suffer from decomposition under the high processing temperatures, followed by depletion of the biocide through leaching into the surrounding environment and finally through depleted bactericidal activity.
  • silver-containing ion exchange, glass, and/or zeolite compounds do not suffer from these shortcomings.
  • Such antimicrobial agents exhibit high temperature stability (>1000°C), do not leach into the environment and provide substantial amounts of the oligodynamic silver ion to provide for the desired extensive durability.
  • inventive antimicrobial articles ultimately made from the inventive raw rubber formulations should exhibit an acceptable log kill rate after 24 hours in accordance with at least one method of either the AATCC Draft Method entitled "Assessment of Antimicrobial Properties on Hydrophobic Textiles and Solid Substrates” or Japanese Method JIS2 2801.
  • Such an acceptable level log kill rate is tested for Staphylococcus aureus or Klebsiella pneumoniae of at least 0.1 increase over baseline.
  • an acceptable level will exist if the log kill rate is greater than the log kill rate for non-treated (i.e., no solid inorganic antimicrobial added) rubber articles (such as about 0.5 log kill rate increase over control, antimicrobial-free rubbers).
  • these log kill rate baseline increases are at least 0.3 and 0.3, respectively for S. aureus and K. pneumoniae; more preferably these log kill rates are 0.5 and 0.5, respectively; and most preferably these are 1.0 and 1.0, respectively.
  • the high end of such log kill rates are much higher than the baseline, on the magnitude of 5.0 (99.999% kill rate). Any rate in between is thus, of course, acceptable as well.
  • log kill rates which are negative in number are also acceptable for this invention as long as such measurements are better than that recorded for correlated non-treated rubber articles.
  • the antimicrobial material present within the rubber article at least exhibits a hindrance to microbial growth.
  • Such rubber articles should exhibit log kill rates of the same degree for other types of bacteria, such as, Psedumonas aeruginosa and Eschericia coli.
  • inventive finished articles made from the inventive raw rubber formulations to provide antifungal benefits as well as antibacterial characteristics.
  • Such versatility is rare among antibacterial compounds; however, without intending to be limited to any particular scientific theory, it appears that the silver ions, and particularly the silver ions present at the article surface in great abundance, provide excellent antifungal properties, at least for certain fungi.
  • another embodiment of this inventive rubber formulation should provide fungal kill durability of at least 15 sequential days for such organisms as Aspergillus niger and mixtures of fungi including Aspergillus niger ATCC 6275, Paecilomyces variotii ATCC 18502, Trichoderma virens ATCC 9645.
  • other compounds may be incorporated within the target pre-vulcanized rubber formulation (and subsequent article), such as zinc oxide, as one example.
  • zinc oxide as one example.
  • a 1:1 ratio (and above) between sulfur molar presence and silver molar presence results in a clear loss of antimicrobial activity within the desired ultimate vulcanized article.
  • greater molar amounts of silver in relation to sulfur provide at least some antimicrobial properties to the desired article.
  • a molar ratio range of from 0.25:1 to about 0.000000001:1 of sulfur to silver ions is thus at least acceptable.
  • the primary curing agent must be of non-sulfur nature (and is preferably, though not necessarily) a peroxide-based compound in order to provide the desired antimicrobial activity for the subject rubber.
  • peroxide curing agents have been utilized for vulcanization of rubber previously, such a different type of curing agent is not widely utilized as a suitable vulcanization catalyst for rubber for a number of reasons. Foremost, such curing agents are much more costly than standard sulfur-based agents and thus the utilization of such peroxides, and the like, as a replacement for the sulfur-based compounds have been rather limited to mostly silicone-based rubbers or, at the very least, non-antibacterial rubber articles.
  • alternatives to such sulfur-based cured articles was to permit utilization of such effective antimicrobial compounds within raw and vulcanized rubber for long-term high log kill rate effects.
  • non-sulfur-based compounds are not readily utilized within the non-silicone industry as vulcanization curing agents, utilization of such curing agents was necessary to provide an effective, ultimate antimicrobial vulcanized rubber article.
  • inventive rubber formulations (either in raw or cured form) listed above are available without such sulfur-based curing agents in any appreciable amounts; most importantly, with the introduction of certain additives, the structural integrity of the rubber formulation is improved to an acceptable level and the efficacy of the antimicrobial components can be controlled simultaneously.
  • the curing agent present within the inventive raw unvulcanized rubber formulation must be at least a majority, and preferably at least about 75% by weight of a non- sulfur-based curing agent.
  • a non- sulfur-based curing agent As discussed above, traditional sulfur and sulfur-based catalysts will not work with the inventive antimicrobial formulations due to chemical reactions between the sulfur atoms and and the biocidal Ag+ ion.
  • non-sulfur-based catalysts such as, for example, and without intending to being limited to peroxides
  • certain compounds provide effective curing for the inventive raw rubber formulations, such as organic peroxides, including dicumyl peroxide, 2,5-bis(t-butylperoxy)-2.5-dimethylhexane, di-(t-butyl-peroxy- isopropyl) benzene, di-(t-butyl-peroxy-trimethyl)-cyclohexane, and the like, and inorganic oxides andor peroxides, including zinc oxide, zinc peroxide, and the like.
  • organic peroxides including dicumyl peroxide, 2,5-bis(t-butylperoxy)-2.5-dimethylhexane, di-(t-butyl-peroxy- isopropyl) benzene, di-(t-butyl-peroxy-trimethyl)-cyclohexane, and the like
  • Such a curing agent should be present in amount of from about 0.5 to about 100 parts per hundred parts of rubber (pphr); more preferably from about 1 to about 50 pphr; and most preferably from about 2 to about 10 pphr, all either as one curing agent alone, or as the combination of any number of different types.
  • additives to the rubber fonnulation include any of the aforementioned silver ion release control additives, as well as accelerators, accelerator activators, antidegradants, softeners, abrasives, colorants, flame retardants, homogenizing agents, internal lubricants, and deodorants. Such components should be present, if at all, in rather low amounts, of from about 0.1 to about 100 pphr.
  • Such a surprising benefit thus permits utilization of such rubber articles as floor coverings (mats, as one example, such as those with carpeted portions or those which are rubber alone; particularly foamed rubber mats for antifatigue properties and reduced specific gravity so as to reduce the chances of machinery damage during such industrial rotaiy launderings and dryings), and other articles which can be easily washed within standard laundry machines.
  • floor coverings such as those with carpeted portions or those which are rubber alone; particularly foamed rubber mats for antifatigue properties and reduced specific gravity so as to reduce the chances of machinery damage during such industrial rotaiy launderings and dryings
  • friction with the subject rubber article surface can remove very slight layers of rubber from the article surface thereby permitting "fresh" silver- comprising crystallites to the surface to act as desired in their antibacterial and/or antifungal capacities.
  • the inventive article produced from the inventive raw rubber formulation exhibits an even dispersion of antimicrobial particles throughout the entire rubber article. Such an even dispersion of the biocide throughout the rubber article thus provides a reservoir of
  • the preferred inventive peroxide-cured rubber articles made from the inventive raw rubber formulations containing the antimicrobial agent can be processed into rubber articles which exhibit excellent antimicrobial qualities as well as antimicrobial efficiency throughout the rubber article's lifetime.
  • rubber articles encompassed within this invention include, but are not limited to hard rubber mats, static dissipative rubber mats, anti- fatigue rubber mats, rubber mats which include a face fiber, rubber link mats, rubber gaskets, rubber medical goods, rubber containing bandages, medical devices, conveyor belts, rubber gloves, rubber belts and rubber wheels used in food processing, rubber clothing, rubber shoes, rubber boots, rubber tubing, and rubber automotive fuel hoses.
  • Such inventive formulations may also be incorporated into a multilayered rubber article in which the antimicrobial agent can be incorporated into any surface layer and still provide the desired antimicrobial efficiency.
  • multilayered rubber articles wherein at least one of such rubber layer exhibits the desired antimicrobial activity and thus is made from an inventive raw rubber formulation.
  • Such layered articles may be adhered together through co- vulcanization, gluing, and the like.
  • layers of other types of materials may be placed being rubber layers as well to provide, as one non-limiting property, better structural stability to the desired multilayered article. The non-limiting preferred embodiments of these rubber formulations are discussed in greater detail below.
  • FEF N550 (CABOT carbon black filler) 100 pphr
  • Ethylene-propylene diene modified Rubber 100 parts di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
  • FEF N550 (CABOT carbon black filler) 100 pphr Paraffinic oil 50 pphr di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(te7"t-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
  • Paraffinic oil 50 pphr di-(tert-butyl-peroxy-isopropyl)benzene 4 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 4 pphr
  • Pentaerythritol tetrastearate (processing aid) 1 pphr
  • Ethyleneglycol dimethacrylate 2.5 pphr di-(tert-butyl-peroxy-isopropyl)benzene 1 pphr di-(tert-butyl-peroxy-trimethyl)-cyclohexane 1 pphr
  • the compounding of ingredients within each formulation can be carried out in an open mill, an internal mixer, or an extruder where intensive mixing within the polymer matrix of each component will take place.
  • the control of temperature rise, due to high shear incorporation of the ingredients, is crucial to ensure that pre- vulcanization (scorch) does not take place during processing.
  • a maximum temperature of 120°C is reached on single stage (pass) mixing through an internal mixer.
  • the compounds can be further processed after mixing into specific forms to allow adequate presentation for manufacturing into products. This could be calendering, extrusion, granulation/pelletization, strip form, fabrication and preforming into specific shaped blanks.
  • the vulcanization of the compounds can be in the form of molding (compression, transfer, injection), continuous extrusion (LCM, UHF[where permissible], autoclave and hot air), and coatings.
  • the vulcanization (cure) temperatures can range from 150°C to 250°C. In this specific situation, the rubber articles were calendared into rough mat structures and then subjected to vulcanization under high temperature and pressure.
  • the following Tables list the antibacterial and antifungal activity of these inventive and comparative samples.
  • the antimicrobial tests followed were AATCC Draft Test Method "Assessment of Antimicrobial Properties on Hydrophobic Textiles and Solid Substrates" and Japanese Method JIS2 2801 for Staphylococcus aureus and the antifungal tests followed were ISO 486 for Aspergillus niger and a mixture of fungi including Aspergillus niger, Paecilomyces variotii, and Trichoderma virens.
  • EPDM Formulation 2 no biocide 0.66 1.35 EPDM Formulation 2 2% biocide B 3.27 5.21 EPDM Formulation 2 2% biocide C 3.27 5.21 EPDM Formulation 3 no biocide 0 -0.28 EPDM Formulation 3 2% biocide B 2.85 4.25 EPDM Formulation 4 no biocide 0 -0.21 EPDM Formulation 4 2% biocide B 2.85 4.25 NBR Formulation 1 no biocide NA 0 NBR Formulation 2 1% biocide A NA 3.87 NBR Formulation 1 1% biocide C NA 4.01 Natural Rubber Formulation no biocide NA -1.98 Natural Rubber Formulation 1 % biocide A NA -1.62 Natural Rubber Formulation 1% biocide C NA -1.19
  • inventive formulations provided inventive vulcanized rubber articles that exhibited improved antimicrobial activity over the same formulations without any antimicrobial compounds present.
  • EPDM Formulation 5 Aspergillus niger 0 0 0 0 0 EPDM Formulation 6
  • EPDM Formulation 5 mixture* 0 0 0 0 0 EPDM Formulation 6 mixture* 0 0 2 2 3
  • NBR Formulation 1 mixture* 0 0 1 2 3
  • the mixture of fungi includes Aspergillus niger ATCC 6275, Paecilomyces variotii ATCC 18502, Trichoderma virens ATCC 9645.
  • Samples were placed on Potato Dextrose Agar (PDA) and inoculated with 10 droplets (lOul each, lOOul total) of 10E5 fungal spores/ml in a synthetic nutrient medium followed by incubation for 7-20 days at 30°C and >90% relative humidity. Efficacy was measured by visual observation of the samples. Observation Rating
  • NBR Formulation 1 no biocide 0 wash -0.33 -0.10
  • NBR Formulation 1 no biocide 1 wash -0.72 -0.14
  • NBR Formulation 1 1 % biocide A 20 wash 4.15 2.08 NBR Formulation 2 1.5% biocide A 0 wash -0.48 NA
  • NBR Formulation 2 1.5% biocide A 1 wash -0.56 NA
  • NBR Formulation 2 1.5% biocide A 20 wash 3.54 3.77
  • the inventive articles not only retained the antimicrobial and thus exhibited antimicrobial activity after washing, such activity actually and unexpectedly improved as the number of washes increased.
  • NBR Formulation 1 no biocide 0 wash 0
  • NBR Formulation 1 no biocide 1 wash 0
  • NBR Formulation 1 1 % biocide A 0 wash 0.02
  • NBR Formulation 1 1 % biocide A 20 wash 1.68
  • NBR Formulation 2 1.5% biocide A 0 wash 0.07
  • NBR Formulation 2 1.5% biocide A 20 wash 1.87 Antimicrobial Control Through Filler and Plasticizer Use as Well as Surface Abrasion
  • inventive articles exhibited controlled release of silver ions dependent upon the presence of different fillers and oils, with the greatest increase occurring with the addition of silica and paraffinic oil with an even greater increase in potential antimicrobial efficacy through the utilization of an abrasion procedure to the article surface.
EP02753761A 2001-03-23 2002-03-01 Antimikrobielle kautschukzusammensetzung Withdrawn EP1381644A4 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US815730 1991-12-30
US09/815,730 US6455610B1 (en) 2001-03-23 2001-03-23 Antimicrobial pre-vulcanized rubber compositions
US09/815,637 US6448306B1 (en) 2001-03-23 2001-03-23 Antimicrobial articles made from nitrile or natural rubber
US815637 2001-03-23
US815483 2001-03-26
US09/815,483 US6555599B2 (en) 2001-03-26 2001-03-26 Antimicrobial vulcanized EPDM rubber articles
PCT/US2002/006422 WO2002077095A2 (en) 2001-03-23 2002-03-01 Antimicrobial rubber compositions

Publications (2)

Publication Number Publication Date
EP1381644A2 true EP1381644A2 (de) 2004-01-21
EP1381644A4 EP1381644A4 (de) 2005-11-02

Family

ID=27420106

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02753761A Withdrawn EP1381644A4 (de) 2001-03-23 2002-03-01 Antimikrobielle kautschukzusammensetzung

Country Status (6)

Country Link
EP (1) EP1381644A4 (de)
JP (1) JP4180922B2 (de)
CN (1) CN1303142C (de)
AU (1) AU2002306639A1 (de)
BR (1) BR0208344A (de)
WO (1) WO2002077095A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7520897B2 (en) 2001-04-11 2009-04-21 Helix Medical, Llc Medical devices having antimicrobial properties
US8317861B2 (en) 2001-04-11 2012-11-27 Helix Medical, Llc Antimicrobial indwelling voice prosthesis
US6638993B2 (en) * 2001-12-12 2003-10-28 Milliken & Company Colored antimicrobial vulcanized rubber articles
BRPI0409713A (pt) * 2003-04-25 2006-05-02 Milliken & Co composições de borracha pré-vulcanizada antimicrobiana e artigos de borracha vulcanizada antimicrobiana
KR100767593B1 (ko) 2004-09-13 2007-10-17 조위수 발가락지압기의 제조방법
US7858674B2 (en) * 2007-02-05 2010-12-28 Milliken & Co. Antimicrobial rubber formulations and molded article
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
JP5674684B2 (ja) 2009-02-03 2015-02-25 マイクロビオン コーポレーション 上皮組織、急性および慢性創傷、細菌性バイオフィルムならびに他の適応症のための消毒剤としてのビスマス−チオール
CN103289408A (zh) * 2012-02-29 2013-09-11 刘芳 一种硅橡胶的制备方法
CN103709524A (zh) * 2013-12-16 2014-04-09 芜湖万润机械有限责任公司 一种抗菌橡胶皮圈
CN104109332A (zh) * 2014-07-03 2014-10-22 深圳市沃特新材料股份有限公司 抗菌热塑性弹性体及其制备方法与应用
CN105061906A (zh) * 2015-07-23 2015-11-18 韦海棉 一种epdm发泡材料及其制备方法
CN105348603A (zh) * 2015-11-09 2016-02-24 安徽冠泓塑业有限公司 一种家用清洁手套加工用的耐皱助剂
CN105801938B (zh) * 2016-04-12 2018-01-09 盐城市合荣文体用品有限公司 一种具有抗菌功能的环保橡皮擦及其制备方法
CN106146960A (zh) * 2016-08-31 2016-11-23 湖北孺子牛鞋业集团有限公司 一种透气型抗菌海绵的制作方法
WO2020028561A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods for treating wounds
WO2020028558A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods of use
CN111019255A (zh) * 2019-12-31 2020-04-17 东莞市特谱峰实业有限公司 一种抗菌橡胶材料及其制备方法
CN111873716A (zh) * 2020-08-05 2020-11-03 江苏中鸿坦达橡胶科技有限公司 一种无钢丝和帘子布的一体硫化免充气轮胎
CN112126138A (zh) * 2020-08-07 2020-12-25 山东玲珑轮胎股份有限公司 一种抑菌橡胶组合物和轮胎
CN111944215A (zh) * 2020-09-09 2020-11-17 河北九度橡胶科技有限公司 一种橡胶抗菌切菜板及其制备方法
CN112111117B (zh) * 2020-10-12 2022-06-14 新疆农业大学 微生物处理的环保型木塑复合材料及制备方法和应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3427264A (en) * 1966-02-07 1969-02-11 Exxon Research Engineering Co Metal-filled plastics comprising a styrene polymer and an elastomer
US4252692A (en) * 1972-09-01 1981-02-24 Raychem Limited Materials having non-linear electrical resistance characteristics
EP0361506A2 (de) * 1988-09-30 1990-04-04 Daikin Industries, Limited Vernetzbare Zusammensetzung mit Fluor enthaltendem Elastomer
US5736591A (en) * 1996-03-01 1998-04-07 The Goodyear Tire & Rubber Co. Latex with resistance to bacterial growth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334311C (en) * 1986-10-29 1995-02-07 Mitsui Chemicals, Incorporated Thermoplastic elastomer composition excellent in heat bondability
JPH07194661A (ja) * 1993-12-29 1995-08-01 Sanpo Bussan Kk 抗菌性ゴムマットの製造方法
DE69507067T2 (de) * 1994-04-14 1999-08-05 Mitsui Chemicals Inc Verfahren zur Herstellung von hochmolekularen Acrylamidpolymeren
JPH08239577A (ja) * 1995-02-28 1996-09-17 Toray Dow Corning Silicone Co Ltd 抗菌性シリコーンゴム組成物
JPH09176495A (ja) * 1995-12-28 1997-07-08 Furukawa Electric Co Ltd:The 屋外用絶縁高分子材料組成物および屋外用高電圧機器
US6332293B1 (en) * 1997-02-28 2001-12-25 Milliken & Company Floor mat having antimicrobial characteristics
JPH11158328A (ja) * 1997-11-27 1999-06-15 Fujikura Rubber Ltd 抗菌性ゴム部品

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3427264A (en) * 1966-02-07 1969-02-11 Exxon Research Engineering Co Metal-filled plastics comprising a styrene polymer and an elastomer
US4252692A (en) * 1972-09-01 1981-02-24 Raychem Limited Materials having non-linear electrical resistance characteristics
EP0361506A2 (de) * 1988-09-30 1990-04-04 Daikin Industries, Limited Vernetzbare Zusammensetzung mit Fluor enthaltendem Elastomer
US5736591A (en) * 1996-03-01 1998-04-07 The Goodyear Tire & Rubber Co. Latex with resistance to bacterial growth

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 131, no. 20060, 18 June 1999 (1999-06-18), Columbus, Ohio, US; abstract no.: 1999:378220, *
DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 18 June 1999 (1999-06-18), MIKI, SHIGEKI ET AL: "Antibacterial rubber parts for use in contact with drinking water" XP002343598 retrieved from STN Database accession no. 1999:378584 -& JP 11 158328 A (FUJIKURA RUBBER WORKS, LTD., JAPAN) 15 June 1999 (1999-06-15) *
DATABASE CA [Online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 4 September 1997 (1997-09-04), SHINKOTANI, NOBUHIRO ET AL: "Tracking-resistant electrically insulating polymer compositions for outdoors with good resistance to moss and fungi and high-voltage outdoor electric machineries therefrom" XP002343597 retrieved from STN Database accession no. 1997:558752 -& JP 09 176495 A (FURUKAWA ELECTRIC CO., LTD., JAPAN) 8 July 1997 (1997-07-08) *
DATABASE WPI Section Ch, Week 199539 Derwent Publications Ltd., London, GB; Class A97, AN 1995-298185 XP002343671 -& JP 07 194661 A (KURARAY CO LTD) 1 August 1995 (1995-08-01) *
See also references of WO02077095A2 *

Also Published As

Publication number Publication date
AU2002306639A1 (en) 2002-10-08
CN1498243A (zh) 2004-05-19
JP2004526029A (ja) 2004-08-26
EP1381644A4 (de) 2005-11-02
BR0208344A (pt) 2004-08-24
WO2002077095A3 (en) 2003-02-27
JP4180922B2 (ja) 2008-11-12
CN1303142C (zh) 2007-03-07
WO2002077095A2 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
US6846871B2 (en) Antimicrobial resin cured rubber articles and prevulcanized compositions
US6555599B2 (en) Antimicrobial vulcanized EPDM rubber articles
US6448306B1 (en) Antimicrobial articles made from nitrile or natural rubber
US7060739B2 (en) Antimicrobial fluoroelastomer rubber articles and compositions
US6455610B1 (en) Antimicrobial pre-vulcanized rubber compositions
EP1381644A2 (de) Antimikrobielle kautschukzusammensetzung
US6638993B2 (en) Colored antimicrobial vulcanized rubber articles
US6852782B2 (en) Antimicrobial articles and compositions made from non-silicone vulcanized rubber
US7858674B2 (en) Antimicrobial rubber formulations and molded article
US6943205B2 (en) Antimicrobial articles and compositions made from styrene butadiene rubber
US20110233810A1 (en) Antimicrobial plastic compositions and methods for preparing same
JP2004526029A5 (de)
WO2004096902A2 (en) Antimicrobial pre-vulcanized rubber compositions and antimicrobial vuclanized rubber articles
US20100240800A1 (en) Biocidal elastomeric compositions and methods of making the same
Zander et al. Microbial susceptibility of various polymers and evaluation of thermoplastic elastomers with antimicrobial additives
US20080248076A1 (en) Antimicrobial rubber bands
KR100665719B1 (ko) 실버 나노 입자가 함유된 고무장갑의 제조 방법
JP2006524740A5 (de)
KR20060113154A (ko) 수산화알루미늄-망간 나노 혼합물이 함유된 고무 장갑 및그 제조 방법

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030919

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 08K 5/14 B

Ipc: 7C 08K 5/00 B

Ipc: 7C 08K 3/34 B

Ipc: 7C 08K 3/10 B

Ipc: 7C 08K 3/08 B

Ipc: 7C 08K 3/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20050919

17Q First examination report despatched

Effective date: 20060322

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100609